GLPG0492

DRUG3 trials

Sponsors

Galapagos NV

Conditions

Healthy

Phase 1

First-in-Human Single Ascending Dose of GLPG0492

CompletedNCT01130818

Galapagos NVHealthy

Start: 2010-05-31End: 2010-09-30Updated: 2024-03-01

Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects

CompletedNCT01397370

Galapagos NVHealthy

Start: 2011-07-31End: 2011-12-31Updated: 2012-02-20

GLPG0492 Pharmacodynamics

CompletedNCT01538420

Galapagos NVHealthy

Start: 2012-01-31End: 2012-04-30Updated: 2012-04-19